@article{TAU28820,
author = {Joep J. de Jong and Kim E. M. van Kessel and Monique J. Roobol and Joost L. Boormans},
title = {Challenges of urine-based molecular assays for the detection of urothelial cancer},
journal = {Translational Andrology and Urology},
volume = {8},
number = {Suppl 5},
year = {2019},
keywords = {},
abstract = {In the issue of Modern Pathology, April 25 2019, Eich and colleagues highlight the relevance of a urine assay called ‘UroSEEK’ as a non-invasive approach for the detection of primary or recurrent urothelial carcinoma of the bladder (UCB). The UROSEEK assay consists of three components; TERTSeqS, UroSeqS, and FastSeqS, which cover molecular alterations in 11 genes that frequently occur in UCB, in addition to aneuploidy (FastSeqS) (1).},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/28820}
}